What is CLEW?
CLEW operates at the intersection of artificial intelligence and critical care medicine. The company provides a real-time analytics platform designed to empower healthcare providers with actionable insights, effectively predicting patient deterioration before it becomes a critical event. By integrating machine learning into the clinical workflow, CLEW helps institutions optimize resource allocation, streamline patient care, and navigate the complexities of modern healthcare regulations.
The platform's core value proposition lies in its ability to lower the cost of care while simultaneously improving patient outcomes. Originally validated within the high-stakes environment of the Intensive Care Unit, the technology is now being adapted to support clinical decision-making across diverse care settings. This strategic expansion positions CLEW as an essential partner for hospital systems aiming to reduce penalties and enhance safety protocols through predictive intelligence.
How much funding has CLEW raised?
CLEW has raised a total of $8.3M across 1 funding round:
Series A
$8.3M
Series A (2017): $8.3M with participation from Pitango Venture Capital and Rhon-Klinikum
Key Investors in CLEW
Pitango Venture Capital
A prominent venture capital firm that partners with visionary entrepreneurs, providing strategic support from early-stage development through to maturity across the health-tech and technology sectors.
Rhon-Klinikum
One of Germany's largest healthcare providers, specializing in integrated medical care services and known for its innovative approach to hospital management and patient-focused treatment delivery.
What's next for CLEW?
Looking ahead, the strategic roadmap for CLEW involves the aggressive deployment of its predictive models across a wider spectrum of hospital departments. The recent capital injection will likely be directed toward enhancing the platform's interoperability with existing electronic health records and expanding the company's footprint in international markets. As healthcare systems increasingly prioritize proactive care over reactive treatment, CLEW is poised to capture significant market share by providing the tools necessary for high-fidelity clinical oversight.
The company's focus on machine learning scalability suggests a future where predictive analytics become the standard of care, rather than a specialized tool. By continuing to refine its algorithms and deepening its partnerships with major healthcare providers, CLEW is set to redefine the efficiency and safety standards of the global medical industry.
